Epidermal growth factor (EGF) receptor (EGFR) can induce cell growth and transformation in a ligand-dependent manner. To examine whether the autophosphorylation of EGFR correlates with the capacity of the activated EGFR to induce cell growth and transformation, we truncated the human EGFR just after residue 1011, removing all three major autophosphorylation sites (DEL1011). Further, a point mutation was introduced at another autophosphorylation site, Tyr-992 -* Phe (DEL1011+F992). The wild-type and mutant receptors were stably expressed in a NIH 3T3 variant cell line that expresses an extremely low level of endogenous EGFR and does not grow with EGF. As expected, DEL1011 and DEL1011+F992 were found to be severely impaired in EGF-induced autophosphorylation, due to the deletion of the appropriate target tyrosines. However, mutant receptors still could induce EGF-dependent DNA synthesis, morphological transformation, and anchorage-independent growth, although the extent of these was significantly reduced when compared with wild-type EGFR. EGF-induced tyrosine phosphorylation of Ras-GTPase activating protein-associated protein p62 and phospholipase C yl was dramatically reduced in the cells expressing DEL1011 and DEL1011+F992. On the other hand, tyrosine phosphorylation of Shc, complex formation of ShcGrb2/Ash, and activation of microtubule-associated protein kinase were still fully induced upon EGF stimulation without binding of Shc or Grb2/Ash to the mutant receptor. Thus, tyrosine phosphorylation of Shc may play a crucial role for activating Ras and generating mitotic signals by the activated EGFR mutant.
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Epidermal growth factor (EGF) receptor (EGFR) is a ligandactivated tyrosine kinase that ultimately delivers mitogenic signals that are relayed to the nucleus. The activated EGFR triggered by EGF is known to phosphorylate its own tyrosine residues as well as intracellular substrate proteins that, in turn, mediate the intracellular signaling cascade (1). All the autophosphorylation sites of EGFR have been identified as a cluster at the carboxyl-terminal domain (2-4). Three major autophosphorylation sites are located at Tyr-1068 Tyr- , -1148 Tyr- , and -1173 (2), and minor ones are located at Tyr-992 and -1086 (3, 4) in human EGFR. Autophosphorylation is considered to be important in regulating the kinase activity for determining substrate specificity (5), but the overall function ofthis region has yet to be elucidated in detail.
Recently, some candidates for direct targets of activated growth-factor receptors have been identified, such as phospholipase C (PLC) yl (6, 7), Ras-GTPase-activating protein
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(GAP) (8), Grb2/Ash (9, 10), and Shc (11) introducing a point mutation with the PCR (nucleotide sequence GAGTAC to GAATTC, a new EcoRI site). To construct human EGFR premature termination mutant, a universal termination linker (CTAGCTAGCTAG) was inserted after aa 1011 [Sac I site, blunted with T4 polymerase (DEL1011)]. The linker generated one extra amino acid after aa 1011 (serine). The point mutation for Phe-992 was introduced into DEL1011 EGFR, resulting in DEL1011+F992 EGFR (Fig. 1A) . To construct the in-frame insertion mutation in the kinase domain, a 12-bp Nco I synthetic DNA linker (5'-CAGCCATGGCTG-3') was inserted at aa 789 (Rsa I site).
The linker generated five extra amino acids after aa 788 (serine, alanine, methionine, alanine, aspartate) and removed [3H]thymidine incorporation (Fig. 2B ). Cells were transfected with the plasmids and subjected to G418-resistant selection, as described in the legend for antiphosphotyrosine, anti-GAP, anti-PLC-yl, or anti-Shc antibodies.
Detection of Kinase Activity with Polyacrylamide Gels Containing Myelin Basic Proteins. Total cell lysates (15 ,g of protein) prepared as above were resolved on SDS/10% PAGE in which myelin basic protein (0.5 mg/ml) was included. The following procedures were done, essentially as described (20) .
RESULTS
The EGFR Mutants with Carboxyl-Terminal Deletion Retain the EGF-Induced Mitogenic and Transforming Activities. To examine the ligand-dependent cellular transformation of the EGFR mutants, a NIH 3T3 cell clone that expresses the endogenous EGFR at very low levels using several criteria (21) was used for transfection with plasmid DNAs carrying the various EGFR constructs (Fig. 1A) . Transfected cells were subject to G418 selection with (10 ng/ml) or without EGF, and the number of transformed foci was counted. The F992 and DEL1O11+F992 mutant EGFRs gave essentially the same level oftransforming activity as that ofthe wild-type EGFR ( (Fig. 3A) . However, as expected from deletion of the major autophosphorylation sites, the DEL1011 and DEL1011+F992 mutants did not show appreciable phosphorylation of the receptor in the total cell lysates (Fig. 3A) orin the immunoprecipitates of the receptors (Fig. 3B) . Parental cells did not show any autophosphorylation of endogenous mouse receptors at detectable levels. In the DEL1011-and DEL1011+F992-expressing cells, several proteins other than EGFR were phosphorylated on tyrosine in an EGF-dependent manner (Fig. 3A) , suggesting that the tyrosine kinase itself in these mutants is still active. We detected tyrosine phosphorylation on 180-kDa c-ErbB2 protein (data not shown). Thus, at least a portion of the phosphorylated bands around 180 kDa in Fig.  3A EGF (8). Upon EGF stimulation, GAP-associated p62 was markedly phosphorylated in the cells expressing wild-type EGFR (Fig. 4A) . On the other hand, in the DEL1011 and DEL1011+F992 EGFR-expressing cells, phosphorylation of GAP complex was hardly detectable, although lysates contained equal amounts of GAP p120, as indicated in Fig. 4A . GAP itself was not clearly phosphorylated, as reported by others (22).
Furthermore, in the DEL1011 and especially the DEL1011+F992 EGFR-expressing cells, EGF-triggered tyrosine phosphorylation of PLC-'yl decreased dramatically (Fig. 4B) . These results suggest that tyrosine phosphorylation of GAP-associated p62 and PLC-yl are not essential for the ligand-induced mitogenesis in these mutants.
DEL1011+F992 EGFR Mutant Can Induce Tyrosine Phosphorylation of Shc-Grb2/Ash Complex and Activation of Mitogen-Activated Protein (MAP) Kinase in an EGF-Inducible Manner. Recently, in EGF-stimulated cells Grb2/Ash has been reported to complex with autophosphorylated EGFR and tyrosine-phosphorylated 46-and 52-kDa Shc proteins (23). It was also suggested that these complexes are upstream of Ras signaling, regulating proliferation and transformation of mammalian cells. In the wild-type EGFR-expressing cells, the ligand EGF induced association of Grb2/Ash with tyrosine-phosphorylated 170-kDa and 52-kDa proteins (Fig.  SA) . The 170-kDa protein was identified as EGFR by immunoprecipitation of cell lysates with anti-Grb2/Ash antibodies and then immunoblotting with anti-EGFR antibody (data not shown). The 52-kDa protein was found to be Shc (Fig. 5 B and  C) . Grb2/Ash itself was not appreciably tyrosine-phosphorylated as previously reported (9). Surprisingly, DEL1011+F992 EGFR could also induce tyrosine phosphorylation of Shc and complex formation of Grb2/Ash with Shc without stable association of the receptor with Grb2/Ash-Shc complex (Fig. 5 A-C) ; in the mutant receptor-expressing cells immunoblotting of antiphosphotyrosine antibody for immunoprecipitates with anti-Shc (Fig.  5B) or anti-Grb2/Ash (Fig. SA) antibodies showed the phosphorylation of Shc on tyrosine and association of Grb2/Ash with the phosphorylated Shc protein. Shc protein stably associated with wild-type EGFR in an EGF-dependent manner, but this association was hardly detectable in EGFstimulated DEL1011+F992 mutant receptor (Fig. SC) (we will discuss this point further).
MAP kinase is reported to be activated in response to EGF and tyrosine-phosphorylated by MEK (MAP kinase kinase). MAP kinase is thought to be downstream of Ras (24). In total cell lysate, 42-kDa (and 44-kDa) proteins were tyrosinephosphorylated in both wild-type and DEL1011 +F992 EGFR-expressing cells but not in the parental cells after EGF addition (Fig. SD Left) . To confirm that these proteins were the activated MAP kinase, we performed a gel kinase assay and detected kinase activity for myelin basic protein, a good substrate for MAP kinase (Fig. SD Right) . By using anti-MAP kinase antibody, tyrosine-phosphorylated p42 was confirmed as MAP kinase (data not shown).
Further, in both wild-type and DEL1011+F992 EGFRexpressing cells, EGF remarkably increased the proportion of the GTP-bound active form of Ras, reaching approximately similar levels, although the parental cells induced it only slightly (data not shown).
These results clearly show that although DEL1011+F992 EGFR cannot induce autophosphorylation efficiently, it can (Fig. 3) or Tyr-992 itself might be involved in suppressing signal transduction.
These DEL1011 and DEL1011+F992 mutants could not phosphorylate GAP-associated p62 or PLC-'yl on tyrosine efficiently (Fig. 4) . On the other hand, the truncated mutant DEL1011+F992 was able to fully induce tyrosine phosphorylation of Shc, complex formation between Shc and Grb2/ Ash, and activation of Ras signaling pathway in an EGF-B EGF 170 Biochemistry: Gotoh et aL inducible manner. These biological activities ofthe autophosphorylation-negative mutant were rather unexpected because the autophosphorylation sites of EGFR and their association with Grb2/Ash or Shc have been thought important for activation of the Ras signaling pathway (23). Therefore, our results strongly suggest that the region of tyrosine kinase domain in the EGFR molecule, without most of the carboxyl-terminal region containing the autophosphorylation sites, alone is sufficient for activation of the downstream signaling pathway (for Shc-Grb2/Ash and Ras proteins) in this system.
There appear two possibilities for phosphorylation of Shc: (i) A "direct" mechanism, in which the EGFR tyrosine kinase domain itself can directly interact with Shc and phosphorylate it on a tyrosine residue. This phosphorylation of Shc may induce complex formation of Shc with Grb2/Ash and activate the Ras pathway through Sos, guanine nucleotide-exchange factor for Ras, as recently reported (26, 27).
(ii) An "indirect (two step)" mechanism, in which some membrane protein(s) are first phosphorylated on tyrosine by EGF-activated mutant receptor; then SH2 domain-containing Shc is recruited near the receptor and phosphorylated on tyrosine by the activated mutant receptor. At this moment, the indirect mechanism cannot be completely ruled out.
Shc is reported to have transforming activity apparently mediated through the Ras pathway. Further, overexpressed Shc protein has been shown to induce Ras-dependent neurite outgrowth in PC-12 cells (23). Because we detected a clear tyrosine phosphorylation of Shc and formation of Shc-Grb2/ Ash complex, which were associated with mitogenic and transforming activity of the mutant EGFR, we suggest that the efficient phosphorylation of Shc is crucial for signal transduciion in this mutant receptor system. A similar case, in which a stable association of tyrosine-phosphorylated Shc with Grb2/Ash, but very low binding of this complex to tyrosine kinase receptor, has been observed in nerve growth factor-Trk receptor system in PC-12 cells (29) . Very recently, Grb2/Ash has been reported to form a ternary complex with the wild-type EGFR and Sos (26, 27) . It would be interesting to study whether EGF induces Shc-Grb2/Ash-Sos complex formation in our mutant-expressing cells.
On the basis of recent studies, it seems clear that the autophosphorylation sites in EGFR are used for the binding and activation of signal transducers in vivo. However, in the avian v-ErbB product and in a structural alteration of EGFR in human glioblastoma, the carboxyl-terminal region of EGFR is significantly deleted (5, 28). Our studies on EGFR deletion mutants, such as DEL1011+F992, suggest the presence of an alternative pathway for cell transformation and growth stimulation by EGFR.
